Bumper Offer - Urjas oil Just @ Rs. 1
Sicriptin 1.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| Adult(Female) |
|
| Adult(Male) |
|
Based on research, the following side effects have been observed when Sicriptin 1.25 Mg Tablet is used -
Moderate
Mild
Is the use of Sicriptin 1.25 Mg Tablet safe for pregnant women?
Pregnant women may get mild side effects from Sicriptin.
Is the use of Sicriptin 1.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Sicriptin. It should only be taken after medical advice.
What is the effect of Sicriptin 1.25 Mg Tablet on the Kidneys?
Very few cases of side effects of Sicriptin on kidney have been reported.
What is the effect of Sicriptin 1.25 Mg Tablet on the Liver?
Sicriptin is rarely harmful for the liver.
What is the effect of Sicriptin 1.25 Mg Tablet on the Heart?
Sicriptin may have severe effects on your heart, so do not take it without first consulting your doctor.
Sicriptin 1.25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Sicriptin 1.25 Mg Tablet unless your doctor advises you to do so -
Is this Sicriptin 1.25 Mg Tablet habit forming or addictive?
Sicriptin 1.25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Sicriptin 1.25 Mg Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Sicriptin 1.25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Sicriptin 1.25 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Sicriptin 1.25 Mg Tablet
There is no information on the effects of taking Sicriptin 1.25 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Sicriptin 1.25 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Sicriptin 1.25 Mg Tablet with alcohol.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 176
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Parlodel® (bromocriptine mesylate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Kripton (bromocriptine mesylate)
